PROCEPT BioRobotics Corporation Interest Expense
PROCEPT BioRobotics Corporation (PRCT) reported Interest Expense of $1.04 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-02
- PROCEPT BioRobotics Corporation interest expense for the quarter ending 2024-03-31 was $1.04M, a 17.95% increase year-over-year.
- PROCEPT BioRobotics Corporation interest expense for the quarter ending 2023-12-31 was $1.13M, a 29.91% increase year-over-year.
- PROCEPT BioRobotics Corporation interest expense for the quarter ending 2023-09-30 was $1.02M, a 29.97% decline year-over-year.
- PROCEPT BioRobotics Corporation interest expense for the quarter ending 2023-06-30 was $965.00K, a 33.03% decline year-over-year.
- PROCEPT BioRobotics Corporation interest expense for fiscal 2023 was $4.00M, a 22.92% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation interest expense for fiscal 2022 was $5.18M, a 10.79% decline from fiscal 2021.
- PROCEPT BioRobotics Corporation interest expense for fiscal 2021 was $5.81M, a 10.44% increase from fiscal 2020.
- PROCEPT BioRobotics Corporation interest expense for fiscal 2020 was $5.26M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.04M 10-Q · filed 2024-05-02 | $2.17M derived: sum of 2 quarters · filed 2024-05-02 | $3.19M derived: sum of 3 quarters · filed 2024-05-02 | $4.15M derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.14M derived: sum of 2 quarters · filed 2024-02-28 | $3.11M derived: sum of 3 quarters · filed 2024-02-28 | $4.00M 10-K · filed 2024-02-28 |
| 2023-09-30 | $1.02M 10-Q · filed 2023-11-02 | $1.98M derived: sum of 2 quarters · filed 2023-11-02 | $2.87M 10-Q · filed 2023-11-02 | $3.74M derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-06-30 | $965.00K 10-Q · filed 2023-07-28 | $1.85M 10-Q · filed 2023-07-28 | $2.72M derived: sum of 3 quarters · filed 2024-05-02 | $4.17M derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-03-31 | $886.00K 10-Q · filed 2024-05-02 | $1.75M derived: sum of 2 quarters · filed 2024-05-02 | $3.21M derived: sum of 3 quarters · filed 2024-05-02 | $4.65M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.32M derived: sum of 2 quarters · filed 2024-02-28 | $3.76M derived: sum of 3 quarters · filed 2024-02-28 | $5.18M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.46M 10-Q · filed 2023-11-02 | $2.90M derived: sum of 2 quarters · filed 2023-11-02 | $4.32M 10-Q · filed 2023-11-02 | $5.76M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.44M 10-Q · filed 2023-07-28 | $2.86M 10-Q · filed 2023-07-28 | $4.30M derived: sum of 3 quarters · filed 2024-02-28 | $5.77M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $1.42M 10-Q · filed 2023-05-04 | $2.86M derived: sum of 2 quarters · filed 2024-02-28 | $4.33M derived: sum of 3 quarters · filed 2024-02-28 | $5.77M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.91M derived: sum of 2 quarters · filed 2024-02-28 | $4.34M derived: sum of 3 quarters · filed 2024-02-28 | $5.81M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.47M 10-Q · filed 2022-11-04 | $2.90M derived: sum of 2 quarters · filed 2022-11-04 | $4.37M 10-Q · filed 2022-11-04 | $6.14M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $1.44M 10-Q · filed 2022-08-05 | $2.90M 10-Q · filed 2022-08-05 | $4.67M derived: sum of 3 quarters · filed 2022-08-05 | $6.06M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $1.46M 10-Q · filed 2022-05-06 | $3.23M derived: sum of 2 quarters · filed 2022-05-06 | $4.62M derived: sum of 3 quarters · filed 2022-05-06 | |
| 2020-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $3.16M derived: sum of 2 quarters · filed 2022-03-22 | $5.26M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $1.39M 10-Q · filed 2021-11-05 | $3.49M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |